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The TAZ transcription co-activator has been shown to pro-
mote cell proliferation and to induce epithelial-mesenchymal
transition. Recently we have demonstrated that TAZ is phos-
phorylated and inhibited by the Hippo tumor suppressor path-
way, which is altered in human cancer. Themechanism of TAZ-
mediated transcription is unclear. We demonstrate here that
TEAD is a key downstream transcription factor mediating the
function of TAZ.Disruption of TEAD-TAZbinding or silencing
of TEAD expression blocked the function of TAZ to promote
cell proliferation and to induce epithelial-mesenchymal transi-
tion, demonstrating TEAD as a key downstream effector of
TAZ. We also identified CTGF, a gene that regulates cell adhe-
sion, proliferation, and migration, as a direct target of TAZ and
TEAD. Our study establishes a functional partnership between
TAZ and TEAD under negative regulation by the Hippo signal-
ing pathway.
TAZ (transcriptional co-activator with PDZ binding motif) is
a transcription co-activator that was initially identified as a
14-3-3-binding protein (1). TAZ contains a conserved WW
domain, a coil-coil domain, a transactivation domain, and a
C-terminal PDZ bindingmotif (2). It is involved in the develop-
ment of multiple organs such as lung, fat, muscle, bone, limb,
and heart tissues (2–5). TAZ also modulates mesenchymal
stem cell differentiation by promoting Runx-2-dependent tran-
scription while repressing peroxisome proliferator-activated
receptor -dependent transcription (3). TAZ knock-out mice
have minor skeletal defects, but pathological changes in the
kidney and lung resemble polycystic kidney disease and pulmo-
nary emphysema, respectively (6, 7). We recently reported that
TAZ is negatively regulated by the Lats tumor suppressor
kinase (8), which is a component of the Hippo tumor suppres-
sor pathway initially defined by genetic studies in Drosophila.
Phosphorylation of TAZ by Lats leads to 14-3-3 binding and
translocation from nucleus to cytoplasm, resulting in func-
tional inactivation of this transcription co-activator (8). This
phosphorylation-dependent inactivation of TAZby Lats is sim-
ilar to the mechanism of YAP regulation (9), which is a co-
activator with similar structure to TAZ, by the Hippo pathway.
Accumulating evidence suggests an important and evolu-
tionary conserved function of the Hippo pathway in control of
tissue growth and cancer development. Both genetic and cell
biological studies from Drosophila indicated that merlin, a
product of the well established human tumor suppressor gene
NF2 (10), acts through the Hippo pathway to inhibit cell prolif-
eration (11).Mutations in Sav andMob, two other components
in the Hippo pathway, have also been identified in human
tumor cell lines (12, 13), further supporting the importance of
the Hippo pathway in human cancer. Interestingly, TAZ is
shown to be overexpressed in 20% of breast cancer samples
and plays an important role in breast tumorigenesis, migration,
and invasion (14). Consistent with this observation, TAZ over-
expression promotes cell proliferation and induces epithelial-
mesenchymal transition (EMT).4 Together, these studies sug-
gest an important role of TAZ inmediating the Hippo pathway
signaling to regulate cell growth and tumorigenesis.
TAZ itself has no DNA binding domain; therefore, it must
bind to DNA binding transcription factors to stimulate down-
stream target gene expression. TAZ has been reported to bind
many transcription factors such as RUNX family, thyroid TF1
(TTF-1), TBX5, PAX3, PAX8, peroxisome proliferator-acti-
vated receptor, andTEAD (2, 4, 5, 15).However, the relevance
of these putative TAZ target transcription factors in mediating
the function of TAZ in promoting cell proliferation and tumor-
igenesis is not clear.
Herewe report that using unbiased biochemical purification,
we identified TEAD family transcription factors as the major
TAZ interacting transcription factors in HEK293T cells. At the
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same time, by screening a human transcription factor library,
we also identified TEAD family transcription factors as the tar-
getsmost potently activated by TAZ.We further demonstrated
that TEAD is indeed indispensable for TAZ to stimulate cell
proliferation, migration, and EMT induction.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—HEK293T cells were cul-
tured in Dulbecco’s modified Eagle’s medium (Invitrogen) sup-
plemented with 10% fetal calf serum (HyClone) and 100
units/ml penicillin and streptomycin (Invitrogen). MCF10A
cells were maintained in Dulbecco’s modified Eagle’s medium/
F-12 medium (Invitrogen) supplemented with 5% horse serum
(Invitrogen), 20 ng/ml epidermal growth factor, 0.5 g/ml
hydrocortisone, 10 g/ml insulin, 100 ng/ml cholera toxin, 100
units/ml penicillin, and streptomycin (Invitrogen). Cell trans-
fection was performed using Lipofectamine 2000 (Invitrogen)
or calcium phosphate methods. Cells were harvested at 24 h
post-transfection for protein analysis or luciferase activity
assay.
To establish stable TAZ-expressing cells, pBabe-TAZ retro-
viruses were generated and used to infectMCF10A cells. Stable
pools were selected with puromycin for 5 days. TAZ stable pool
cells were seeded in 6-well plates with 1  105 cells/well in
triplicates. Cell growth was counted every day for 7 days.
Streptavidin-binding Peptide (SBP) Purification of TAZ Pro-
tein Complex—SBP-TAZ stable 293T cells from ten 150-mm
plates were collected and lysed in 40 ml of 0.3% Nonidet P-40
buffer (50mMTris-HCl, 150mMNaCl, pH 7.5) containing pro-
tease and phosphatase inhibitors. SBP-TAZ in the supernatant
was precipitated for 3 h with 100 l of streptavidin resin (GE
HealthCare, 17-5113-01), which was then washed 3 times with
0.3% Nonidet P-40 buffer followed by washing with 50 mM
NH4HCO3 3 times. The precipitated protein was digested with
trypsin (22). The supernatant was collected, dried, and dis-
solved in 10% acetonitrile, 0.8% formic acid solution. The pep-
tides were analyzed by MS/MS.
Luciferase Activity Assay—For the luciferase reporter assay,
293T cells were seeded in 24-well plates. A mixture of 5
upstream activating sequence-luciferase reporter, Renilla, and
the indicated plasmids was cotransfected. Twenty-four hours
after transfection, cells were lysed, and luciferase activity was
measured using a dual-luciferase reporter assay system
(#E1960; Promega) following the manufacturer’s instructions.
The luciferase activity was measured by a luminometer (model
TD-20/20). Transfection efficiency was normalized to thymi-
dine kinase-driven Renilla luciferase activity as the internal
control.
RNA Isolation and Real-time PCR—Total RNA was isolated
from cultured cells using Trizol reagent (Invitrogen). cDNA
was synthesized by reverse transcription using oligo(dT) as the
primer and proceeded to real-time PCR with gene-specific
primers in the presence of SYBR Premix Ex Taq (#DRR041A;
TaKaRa). The relative abundance of mRNA was calculated by
normalization to glyceraldehyde-3-phosphate dehydrogenase
mRNA.
Western Blotting Analysis—Protein lysates were prepared
fromMCF10A,MCF10ATAZ, andmutants stable pool cells in
a buffer containing 50mMTris-HCl, pH8.0, 150mMNaCl, 0.1%
SDS, 0.5% deoxycholate, 1% Nonidet P-40, 1 mM EDTA, 1 mM
phenylmethylsulfonyl fluoride, 25 mMNaF, andmixture prote-
ase inhibitors (Roche Applied Science). Tissue lysate (40 g)
was resolved by SDS-PAGE followed byWestern blotting anal-
ysis. Antibodies to FLAG (#A00170 (GenScript) or #A2220
(Sigma)), E-cadherin (monoclonal antibody (mAb) #610405;
BD Biosciences), N-cadherin (mAb #610920; BD Biosciences),
vimentin (mAb #550513, BD Biosciences), occludin (SC-5562;
Santa Cruz Biotechnology), and -actin (13E5, #4970; Cell Sig-
naling) were purchased commercially.
For immunoprecipitation experiments, 500 g of cell lysate
was incubated with anti-FLAG M2-agarose for 2 h at 4 °C.
Beads were washed 3 times with lysis buffer and centrifuged at
5000 g for 5min between each wash. Protein was eluted from
beads with 50 l of Laemmli sample buffer (Bio-Rad). Lysates
were resolved on 8–10% SDS-PAGE gels and transferred onto
nitrocellulose (Bio-Rad) for Western blotting.
Chromatin Immunoprecipitation (ChIP)—ChIP analysis was
performed as previously described (23). Briefly, formaldehyde
was added directly to cell culturemedia to a final concentration
of 1% at room temperature. Thirty minutes later glycine was
added to a final concentration of 0.125M. The cells werewashed
with ice-cold phosphate-buffered saline (PBS), scraped, and
collected in cold PBS followed by steps of micrococcal nuclease
digestion and sonication. After immunoprecipitationwith anti-
FLAG M2 beads, immunoprecipitated DNA were decross-
linked, and proteinase K was digested and purified for PCR
amplification. The ChIP-enriched DNA was subjected to PCR
using promoter-specific primers (connective tissue growth fac-
tor (CTGF) sense, 5-GGAGTGGTGCGAAGAGGATA-3;
CTGF antisense, 5-GCCAATGAGCTGAATGGAGT-3).
Wound-healing Assay—Monolayer cells were wounded with
a sterile plastic pipette tip. Cell migration was observed 16 h
later by microscopy.
Matrigel Assay—Matrigel assays were performed as reported
previously with minor modifications (5). Briefly, cell culture
plates were precoated with 100% Matrigel (BD Pharmingen).
Cells (5000) were plated onto the Matrigel bed and cultured
with mammary epithelial cell growth medium supplemented
with hydrocortisone, insulin, epidermal growth factor, fetal
bovine serum, and 2% Matrigel. Acinar formation was moni-
tored by microscopy.
RESULTS
TEADs Are Major TAZ Binding Transcription Factors—As a
transcription coactivator, TAZ must interact with a down-
stream transcription factor to induce gene expression. To iden-
tify TAZ target transcription factors, we performed TAZ affin-
ity purification. TAZwas expressed as a fusion protein with the
SBP, which has high affinity toward streptavidin and can be
easily purified by streptavidin beads. To decrease nonspecific
interactions caused by high expression level, we used retrovirus
to establish 293T stable cell clones with low expression level of
SBP-TAZ. SBP-TAZ was purified by streptavidin-Sepharose
pulldown, and the purified proteins were detected by Western
blotting (Fig. 1A) and silver staining (Fig. 1B). SBP-TAZ and
several other proteins were specifically present in cells express-
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ing SBP-TAZ but not in vector control cells (Fig. 1B). After SBP
purification, we performed on-beads trypsin digestion, and the
entire digestion mixture was analyzed by tandem liquid chro-
matography and mass spectrometry (LC-MS/MS). This purifi-
cation strategy identified multiple putative TAZ-interacting
proteins. Notably, all four TEAD family members, TEAD1,
TEAD2, TEAD3, and TEAD4, were identified with high
scores. In fact, multiple peptides for each TEAD protein
were identified (Fig. 1C). These peptides were absent from
control purification products from cells infected with the
SBP vector. Western blotting of the affinity purified SBP-
TAZ further confirmed that endogenous TEAD4 was co-
purified with SBP-TAZ (Fig. 1D).
TEAD Mediates TAZ-dependent Gene Induction—We also
performed an independent screen for TAZ target transcription
factors. This screen is based on the ability of TAZ to activate
target transcription factors in a luciferase reporter assay.
Clones of the Gal4-TF library (a total of 1100 putative human
transcription factors fused with Gal4 DNA binding domain)
and 5 upstream activating sequence-luciferase reporter
driven by five Gal4 binding elements were individually
co-transfected with or without TAZ. If a transcription factor is
activated by TAZ, co-expression of TAZ should increase lucif-
erase activity. This unbiased screen identified TEAD2, -3, and
-4 as the top three transcription factors that are most potently
activated by TAZ (Fig. 2A). TEAD1 is not in the library but was
also confirmed to be activated by TAZ separately (Fig. 2A).
Noteworthy, TEAD3 andTEAD4weremore potently activated
by TAZ than TEAD1 and TEAD2 (Fig. 2A). These results com-
plemented the TAZ affinity purification to establish TEADs as
major transcription factors activated by TAZ.
We previously observed that YAPS94A mutation diminished
the interaction between YAP and TEAD (9). Interestingly, this
residue essential for TEAD binding is conserved in TAZ. We,
therefore, generated TAZS51A mutant, which is the equivalent
to YAPS94Amutant.We found that TAZS51A or TAZS51Dmuta-
tion abolished the interaction between TAZ and TEAD4 (Fig.
2B). TAZS51A mutant was also defective in TEAD4 activation
(Fig. 2C), indicating that the TAZ-TEAD interaction is func-
tionally important for TAZ to activate TAED4 and, presum-
ably, all TEAD family transcription factors.
To further investigate themechanismofTAZ in gene expres-
sion, mRNA expression from vector or TAZ-overexpressing
MCF10A cells, which is an immortalized but non-transformed
human mammary epithelial cell line, were determined by
microarray (supplemental Table 1). Among many genes
induced, we observed a robust induction of CTGF, amember of
the CCN family of cysteine-rich-secreted proteins that regu-
lates a wide variety of cellular functions, including adhesion,
proliferation, migration, and differentiation (16, 17). CTGF has
also been implicated in cell growth and cancer. We further
examined whether TAZ stimulates CTGF expression and the
role of TEAD in this process. We found that TAZ expression
strongly activated the luciferase reporter driven by the CTGF
promoter (Fig. 2D). Furthermore, co-expression of a dominant
negative TEAD1C, which has a deletion of the C-terminal
TAZ interacting region but still retains the DNA binding
domain, strongly blocked the ability of TAZ to stimulate CTGF
FIGURE 1. TEADs are the major TAZ binding transcription factors. A, SBP-TAZ is stably expressed in 293T cells. Retrovirus was used to establish SBP-TAZ
stable cell clones. SBP-TAZ was purified with streptavidin-Sepharose, and the purified proteins were examined by Western blotting. B, silver staining for the
streptavidin-Sepharose purified proteins. The streptavidin-Sepharose purified proteins were separated by SDS-PAGE for silver staining. C, identification of
multiple TEAD peptides from TAZ immunocomplex. After SBP purification, trypsin digestion was performed on beads, and the total digestion mixture was
directly analyzed by liquid chromatography-MS/MS. The identified peptides for each TEAD family member were shown. D, endogenous TEAD4 was coprecipi-
tated by SBP-TAZ. Cell lysate was precipitated with SBP-Sepharose followed by Western blotting with antibodies against TAED4 and TAZ.
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promoter in a dose-dependent manner (Fig. 2D). TEAD1C
functions as a dominant negative probably by competing with
endogenous TEAD for binding to target gene promoters. These
observations indicate thatTEAD is required forTAZ to activate
the CTGF promoter.
To examine a direct interaction of TAZ with CTGF promoter,
ChIP was performed in vector or FLAG-TAZ-expressing 293T
cells with anti-FLAG antibody. We found that FLAG-TAZ could
bind to theCTGFpromoter (Fig. 2E). In contrast, theTEADbind-
ing-defective TAZS51A mutant does not bind to CTGF promoter,
supporting our model that TEAD mediates the interaction
between TAZ and CTGF promoter. These observations are con-
sistent with a previous study demonstrating that the CTGF pro-
moter contains putative TEAD binding sites, and its expression is
regulated by TEAD (9).We further determined the effect of TAZ
expression on endogenous CTGF mRNA level. CTGF mRNA
expression is inducedbywild-typeTAZandevenmorestronglyby
TAZ4SA, which is a constitutively active mutation because all the
Lats inhibitory phosphorylation sites are abolished in this mutant
(Fig. 2E). However, the TEAD binding-defective TAZS51A or
TAZ4SA-S51A could not induce CTGF expression (Fig. 2E).
Together, we conclude that TEAD plays an essential role in the
induction of CTGF by TAZ.
TEAD Binding Is Required for TAZ to Stimulate Cell
Proliferation—In our previous study, we have established that
TAZ acts as a downstream component of theHippo pathway to
promote cell proliferation (8). To examine the role of TEAD in
the ability of TAZ to stimulate cell growth, we established
MCF10A stable cells expressing TAZ wild-type or mutant pro-
teins. As expected, MCF10A cells expressing TAZ proliferated
much faster than the vector control cells (Fig. 3A). Mutation of
serine 51 to alanine, which disrupted TEAD binding (Fig. 2B),
largely abolished the ability of TAZ to stimulate MCF10A cell
proliferation (Fig. 3A), suggesting the importance of TEAD
binding for the ability of TAZ to stimulate cell proliferation.
Mutation of the four putative Lats phosphorylation sites results
in a constitutive active TAZ4SA mutant that is more active in
stimulating cell proliferation than the wild-type TAZ (Fig. 3A).
TAZ with combined 4SA and S51A mutations (TAZ4SA-S51A)
was largely inactive to promote MCF10A proliferation (Fig.
3A), further supporting the notion thatTEADbinding is impor-
tant for TAZ to stimulate cell proliferation and that TEAD is a
downstream effector of the Hippo pathway.
We further investigated the requirement of TEAD binding
for TAZ to stimulate MCF10A cell proliferation in a three-
dimensional culture onMatrigel. MCF10A cells can form acini
FIGURE 2. TEAD mediates TAZ-dependent gene induction. A, TAZ activates TEAD family transcription factors. 5 upstream activating sequence-Luciferase
reporter, the indicated Gal4-fused transcription factors, and renilla were co-transfected with or without TAZ. The renilla activity normalized luciferase activity
in the absence of TAZ was set to 1. B, Ser-51 of TAZ disrupts its interaction with TEAD4. The indicated plasmids were cotransfected into 293T cells. FLAG-TAZ was
immunoprecipitated (IP) and probed with the indicated antibodies. C, TAZS51A loses the ability to activate TEAD4. The indicated plasmids were co-transfected
with a 5 upstream activating sequence-luciferase reporter into 293T cells. Luciferase activity was measured and normalized to renilla activity. WT, wild type.
D, dominant-negative TEAD1 blocks TAZ-mediated activation of CTGF promoter. The indicated plasmids were coexpressed in 293T cells. Cells were harvested
for measurement of luciferase activity 24 h after transfection. E, TAZ binds to CTGF promoter. A ChIP assay was performed with anti-FLAG antibody using 293T
cells stably expressing FLAG-TAZ. The presence of CTGF promoter was detected by PCR. WT, wild type. F, TEAD is required for TAZ-induced CTGF induction. RNA
was extracted from the indicated MCF10A stable pools, and CTGF mRNA levels were analyzed by quantitative RT-PCR.
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in Matrigel with defined size. Such a culture condition is more
physiologically relevant to recapitulate the environment and
morphogenesis ofmammary epithelial tissue.Weobserved that
the size of MCF10A cell acini was significantly increased by
expression of TAZ and more potently by expression of
TAZ4SA (Fig. 3B). However, the expression of the TAZS51A
or TAZ4SA-S51A TEAD binding-defective form did not
increase acinar size (Fig. 4B). Therefore, TEAD binding is
essential for TAZ to promote cell proliferation.
To provide further evidence for the functional importance of
TEAD-TAZ interaction, we utilized shRNA to knock down
TEADs in MCF10A cells. We have previously generated a len-
tiviral construct, shTEAD1/3/4, which can successfully knock
down TEAD1, TEAD3, and TEAD4 simultaneously (9). We
examined the effect of TEAD1/3/4 knockdown on TAZ-in-
duced cell proliferation. Our data further support an important
role of TEAD inTAZ-mediated stimulation of cell proliferation
as TEAD knockdown dramatically retarded proliferation of the
TAZ4SA-expressing cells (Fig. 3, C and D). Collectively, these
results provide compelling evidence that TEAD is required for
the function of TAZ in promoting cell proliferation.
TEAD Binding Is Essential for TAZ to Induce EMT—We previ-
ously reported that expression of wild-type TAZ or the active
TAZ4SA mutant in MCF10A cells induces EMT. We examined
whether TEAD binding is required for TAZ to promote EMT in
MCF10A cells. TAZ or TAZ4SA expression induces dramatic
EMT-likemorphological changes, including a loss of cell-cell con-
tact and cell scattering (Fig. 4A). However, both TEAD binding-
deficient mutant TAZS51A and TAZ4SA-S51A were unable to pro-
mote suchmorphological alterations (Fig. 4A).Wealsoperformed
F-actin staining to examine the organization of cytoskeleton. Cells
expressingTAZexhibited disorganization of cell junction, and the
TAZ4SA-expressing cells displayed a dramatic increase of stress
fibers along with disorganization of cell junction, consistent with
the EMT phenotypes (Fig. 4B). In contrast, the TAZS51A- and
TAZ4SA-S51A-expressing cells exhibited normal structures of
cytoskeleton as observed in theMCF10A vector control cells (Fig.
4, A and B). These data indicate that TEAD binding is important
for TAZ to induce mesenchymal-like morphological changes in
MCF10A cells.
Western blotting for EMTmarkers was performed to further
confirm whether TEAD-TAZ binding plays a role in TAZ-in-
FIGURE 3. Disruption of TAZ-TEAD binding abolishes the function of TAZ in promoting cell proliferation. A, growth curve of MCF10A cells stably
expressing wild-type or mutant TAZ as indicated. B, TAZ4SA-S51A is compromised in inducing enlarged MCF10A cell acini. Indicated MCF10A-derived stable cells
were cultured in three-dimensions on reconstituted basement membrane for 14 days before the pictures were taken. WT, wild type. C, growth curve of TAZ4SA
expressing MCF10A cells. TEAD1/3/4 knockdown by shRNA are indicated. D, TEAD knockdown inhibits MCF10A cell acinar growth. TAZ4SA-expressing MCF10A
cells were infected with control or TEAD1/3/4 shRNA lentivirus. Cell growth in Matrigel is shown.
TEAD Transcription Factors Mediate the Function of TAZ
MAY 15, 2009 • VOLUME 284 • NUMBER 20 JOURNAL OF BIOLOGICAL CHEMISTRY 13359
duced EMT. Epithelial marker E-cadherin and occludin were
indeed down-regulated in cells expressing TAZ and more sig-
nificantly in cells expressing TAZ4SA (Fig. 4C). Consistent with
the down-regulation of epithelial markers, expression of mes-
enchymalmarkersN-cadherin and vimentinwere up-regulated
inTAZ4SA-expressing cells but not in theTEADbinding-defec-
tive TAZ4SA-S51A-expressing cells (Fig. 4C). The levels of
N-cadherin and E-cadherinmRNAwere also regulated by TAZ
but not by the TEAD binding-defective mutants in a manner
similar to their corresponding protein levels (Fig. 4D). Further-
more, infection of MCF10A/TAZ4SA cells with this shTEAD1/
3/4 lentivirus inhibited the ability of TAZ4SA in promoting cell
proliferation and EMT-likemorphological alterations (Fig. 4E).
Together, our data indicate that TEAD-TAZ binding is
required for TAZ to induce EMT in MCF10A cells.
TEAD Is Required for TAZ to Promote Cell Migration—Cell
migration plays an important role in cancer development. To
examine the requirement of TEAD binding in mediating
TAZ function in promoting cell migration, we performed
wound-healing assays. Expressing of TAZ could promote the
wound healing in culturedMCF10A cells (Fig. 4A). Mutation
of the Lats phosphorylation sites dramatically increased the
effect of TAZ to promote wound closure. However, cells
expressing TAZS51A and TAZ4SA-S51A exhibited minimal
wound closure, indicating that TEAD binding is required for
TAZ to promote cell migration (Fig. 5A). This observation is
FIGURE 4. Disruption of TEAD-TAZ binding blocks the ability of TAZ to promote EMT. A, S51A mutation in TAZ blocks TAZ induced EMT-like morphological
change. Phase-contrast images of MCF10A cells stably expressing TAZ and its mutants are shown. B, Ser-51 mutation abolishes actin organization remodeling
induced by TAZ. Cells were stained with rhodamine-conjugated phalloidin. C, Ser-51 mutation abolishes TAZ-induced EMT. Cell lysates from MCF10A cells
stably expressing the wild-type (WT) and mutant TAZ were analyzed with the indicated epithelial and mesenchymal marker antibodies. D, Ser-51 mutation
abolishes TAZ-induced change of E-cadherin and N-cadherin mRNA expression. Total RNA was extracted from MCF10A cells stably expressing the wild-type
and mutant TAZ, and quantitative RT-PCR was employed to determine E-cadherin and N-cadherin mRNA levels. E, TEAD1/3/4 knockdown blocks TAZ-induced
EMT-like morphological change. TEAD1/3/4 were knocked down by shRNA. Indicated MCF10A stable cells were cultured, and the pictures were taken.
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consistent with a defect of TAZS51A or TAZ4SA-S51A in
inducing EMT.
We also examined the effect of TEAD knockdown on the
activity of TAZ to promote cell migration. Knockdown of
TEAD significantly compromised the ability of TAZ4SA in
wound healing when compared with cells infected with scram-
ble shRNA viruses (Fig. 5B). Collectively, these results support
the conclusion that TEAD is required for the function of TAZ
in promoting cell migration.
DISCUSSION
Breast cancer is the second-leading cause of cancer-related
death in females inUnited States(18). Elucidating themolecular
mechanisms underlying the development and progression of
breast cancer is critical for its prevention, diagnosis, and ther-
apy. TAZhas been reported to promote cell proliferation, EMT,
and cell migration in normalmammary epithelial cells (8). TAZ
expression level has also been reported to correlate with breast
cancer cell invasiveness (14). Elevated TAZ expression is
observed inmore than 20% of breast cancers especially invasive
ductal carcinomas (14). Consistently, TAZ has also been shown
to be inhibited by the Hippo tumor suppressor pathway, which
contains well established human tumor suppressor NF2 and
other genes mutated in human cancer, such as Sav and Mob.
However, the key transcription factors mediating TAZ func-
tion in promoting cell proliferation, migration, and EMT have
not been defined, although several transcription factors, such as
RUNX, peroxisome proliferator-activated receptor , Tbx5,
and Pax3, have been implicated to act downstream of TAZ
(3–5). The lack of systemic study on TAZ transcription factor
targets is certainly a reason for the absence of this information;
therefore, we addressed this question by a combination of bio-
chemical purification and functional screening. Interestingly,
TAZ affinity purification identified all four of the TEAD family
transcription factors as TAZ-binding proteins. Besides the four
TEAD proteins, only two additional transcription factors were
identified in our affinity purification but with lower mass spec-
trometry scores (data not shown). This strongly suggests
TEADs as the major TAZ transcription factor partners at least
in HEK293T cells. Consistently, an independent screen of a
Gal4 fusion human transcription factor library identified three
of the four TEAD family transcription factors as the most
potent targets of TAZ determined by the reporter activation
assay, whereas the other TEAD family member, TEAD1, was
not present in the library. Together, these data support the
notion that TEADs are bona fide TAZ target transcription fac-
tors, although other transcription factors may be used for the
diverse functions of TAZ in other cell types.
We demonstrated in this report that TEAD mediates TAZ
function in promoting cell proliferation, EMT, and cell migra-
tion, which are all involved in cancer initiation and progression.
FIGURE 5. TEAD is required for TAZ function in promoting cell migration. A, Ser-51 mutation abolishes TAZ-induced cell migration. Migration of MCF10A
cells stably expressing the wild-type and mutant TAZ was determined by a wound-healing assay. B, TEAD1/3/4 knockdown blocks TAZ induced cell migration.
Migration ability of indicated MCF10A stable cells was determined by a wound-healing assay.
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We manipulated TAZ-TEAD interaction mainly by two
approaches; that is, a point mutation on TAZ (S51A) that abol-
ishes TAZ-TEAD interaction and shRNA knockdown of
TEAD. Both approaches support that perturbation of TAZ-
TEAD interaction aborts or attenuates the effect of TAZ on
promoting cell proliferation in two-dimensional or three-di-
mensional culture, inducing EMT-like morphological changes
and EMTmolecular markers and promoting wound closure in
wound healing cell migration assay. Therefore, TAZ-TEAD
interaction might be a target of therapy for cancers showing
elevated TAZ expression or Hippo pathway dysfunction.
Another interesting aspect of the function of TAZ-TEAD in
inducing EMT is its implication in stem cell self-renewal. A
recent report suggested a correlation between mesenchymal
traits and the gain of epithelial stem cell properties using
immortalized human mammary epithelial cells as a model sys-
tem (19). Interestingly, TAZ has recently been implicated in
maintaining stem cell self-renewal ability, although this func-
tion of TAZ has been attributed to its ability to regulate Smad
subcellular localization (20). It will be interesting to test
whether TEAD also contributes to the ability of TAZ to main-
tain stem cell self-renewal or cancer stem cell population in
breast cancer.
To explore the regulation of gene expression by TAZ-TEAD,
we used gene expression microarray to examine genes induced
by TAZ expression. As expected for a transcription co-activa-
tor, ectopic expression of TAZ induces expression of many
genes. We compared the gene expression profile of TAZ- or
YAP-overexpressing MCF10A cells. Interestingly, although
TAZ and YAP are highly homologous and there are significant
portion of genes commonly induced by both TAZ and YAP,
there are also many genes uniquely induced by TAZ or YAP
(supplemental Fig. 1 and Table 1). We previously reported that
many YAP target genes are TEAD-dependent. Importantly, by
looking at the distribution of 55 high confidence TEAD-de-
pendent YAP target genes (those induced byYAP-wild type and
active 5SA protein but not YAP-S94A TEAD binding-deficient
protein), we found that 32 of them are common among YAP-
and TAZ-inducible genes, whereas 23 of them are uniquely
induced by YAP. Therefore, TAZ and YAP can use TEAD fam-
ily transcription factors to induce sets of common as well as
distinct target genes, whichmight be responsible for the shared
and unique functions of TAZ and YAP. To further confirm the
function of TEAD in TAZ-dependent gene induction, we
showed that CTGF is a direct target gene of TAZ-TEAD in
mammalian cells and TEAD is required for TAZ to induce
CTGF expression. Interestingly, CTGF has been implicated in
multiple human cancer development and progression, consist-
ent with the positive role of TAZ in tumorigenesis (16, 17, 21).
In summary, our study identified TEAD family transcription
factors as major TAZ target transcription factors and estab-
lished a functional partnership between TAZ and TEAD in cell
proliferation, EMT, and cell migration. These findings advance
our understanding of the role of TAZ in cancer development
and provide a potential therapeutic target for human breast
cancer treatment.
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